CAR T-Cell Therapy in Multiple Myeloma

The introduction of CAR (chimeric antigen receptor) T-cell therapy into clinical practice has revolutionized the treatment landscape of relapsed/refractory multiple myeloma (RRMM). At present, two B-cell maturation antigen (BCMA)-targeted CAR T-cell therapies, idecabtagene vicleucel and ciltacabtagene autoleucel, are used in clinical practice, but only ciltacabtagene autoleucel is approved in Brazil. In this review, we explore the advantages and challenges of integrating CAR T-cell therapy earlier in the RRMM treatment course.

Authors

Institutions

Publication Details

Journal
JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY
Published
2026-11-20
DOI
https://doi.org/10.46765/2675-374x.2025v7n1e390
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

CAR T-Cell Therapy in Multiple Myeloma

Ângelo Maiolino, João Tadeu Damian Souto Filho, Mariana Nassif Kerbauy, Abrahão Elias Hallack Neto et al.
2 links
JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY
CAR-T cell therapy research
article

CAR T-Cell Therapy in Multiple Myeloma

Ângelo Maiolino, João Tadeu Damian Souto Filho, Mariana Nassif Kerbauy, Abrahão Elias Hallack Neto, Edvan de Queiroz Crusoé, Roberto José Pessoa de Magalhães Filho, Vania Tietsche de Moraes Hungria, Fernando Vieira Pericole de Souza
article en

Abstract

The introduction of CAR (chimeric antigen receptor) T-cell therapy into clinical practice has revolutionized the treatment landscape of relapsed/refractory multiple myeloma (RRMM). At present, two B-cell maturation antigen (BCMA)-targeted CAR T-cell therapies, idecabtagene vicleucel and ciltacabtagene autoleucel, are used in clinical practice, but only ciltacabtagene autoleucel is approved in Brazil. In this review, we explore the advantages and challenges of integrating CAR T-cell therapy earlier in the RRMM treatment course.

JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPYVol. 7(1)
Universidade Federal de Juiz de Fora (BR), Universidade Federal do Rio de Janeiro (BR), Universidade Federal da Bahia (BR), Universidade Estadual de Campinas (UNICAMP) (BR), Hospital Israelita Albert Einstein (BR), São Germano Oncologia (BR), Prefeitura Municipal de Campos dos Goytacazes (BR)
Good health and well-being
CAR-T cell therapy research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
CAR T-Cell Therapy in Multiple Myeloma — Ângelo Maiolino, João Tadeu Damian Souto Filho, et al. · JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY (2026) | TGRS Research Map | TGRS